STOCK TITAN

BioLife Solutions (BLFS) CMO has 470 shares withheld to cover RSU tax bill

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

BioLife Solutions Chief Marketing Officer Todd Berard had 470 shares of common stock withheld by the company on the RSU vesting date to cover tax obligations. This was a tax-withholding disposition, not an open-market sale. After this withholding, he directly holds 162,942 shares of BioLife Solutions common stock.

Positive

  • None.

Negative

  • None.
Insider Berard Todd
Role Chief Marketing Officer
Type Security Shares Price Value
Tax Withholding Common Stock 470 $26.04 $12K
Holdings After Transaction: Common Stock — 162,942 shares (Direct, null)
Footnotes (1)
  1. [object Object]
Shares withheld for taxes 470 shares Tax-withholding disposition on restricted stock unit release
Reporting price per share $26.04 per share Value used for the 470 withheld shares
Post-transaction holdings 162,942 shares Direct ownership after tax withholding
restricted stock units financial
"arose upon the release of restricted stock units"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
tax withholding obligations financial
"withheld by the Issuer to satisfy tax withholding obligations"
tax-withholding disposition financial
"transaction_action: "tax-withholding disposition""
A tax-withholding disposition is an event or transaction—such as selling or transferring securities, exercising options, or receiving compensation—that triggers a requirement to hold back part of the payment and remit it to tax authorities. It matters to investors because it reduces the cash they receive immediately and can change the timing and amount of taxable income, like a cashier taking a portion of your sale proceeds to pay taxes before you get the rest.
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Berard Todd

(Last)(First)(Middle)
3303 MONTE VILLA PARKWAY
SUITE 310

(Street)
BOTHELL WASHINGTON 98021

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
BIOLIFE SOLUTIONS INC [ BLFS ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
Chief Marketing Officer
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
06/18/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock06/18/2026F470(1)D$26.04162,942D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. Represents the number of shares withheld by the Issuer to satisfy tax withholding obligations of the reporting person that arose upon the release of restricted stock units.
Remarks:
/s/ Todd Berard06/22/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did BioLife Solutions (BLFS) report for Todd Berard?

BioLife Solutions reported that Chief Marketing Officer Todd Berard had 470 shares of common stock withheld to satisfy tax obligations upon the release of restricted stock units, according to a Form 4 insider filing.

Was the BioLife Solutions (BLFS) Form 4 transaction an open-market sale?

No, the Form 4 shows a tax-withholding disposition. The 470 BioLife Solutions shares were withheld by the company to cover Berard’s tax liability from restricted stock unit vesting, not sold on the open market.

How many BioLife Solutions (BLFS) shares were withheld for taxes?

A total of 470 shares of BioLife Solutions common stock were withheld. The filing states these shares covered Chief Marketing Officer Todd Berard’s tax withholding obligations when his restricted stock units were released.

What price per share was used for the BioLife Solutions (BLFS) tax withholding?

The Form 4 lists a price of $26.04 per share for the 470 withheld shares. This value is used solely for reporting the tax-withholding disposition related to the vesting of restricted stock units.

How many BioLife Solutions (BLFS) shares does Todd Berard hold after this transaction?

Following the tax-withholding transaction, Todd Berard directly holds 162,942 shares of BioLife Solutions common stock. This post-transaction balance is disclosed in the Form 4 as his direct ownership position.

What does transaction code F mean in the BioLife Solutions (BLFS) Form 4?

Transaction code F indicates a tax-withholding disposition. In this BioLife Solutions Form 4, it shows shares were withheld by the issuer to pay Todd Berard’s tax liability on restricted stock unit vesting.